IDIVAL obtains financing for two of the three projects presented in the Call for Challenges – Collaboration according to the proposal for a provisional resolution to grant aid to the call for early processing of 2019 for R + D + i projects “Challenges – Collaboration” of the Program State Research, Development and Innovation Oriented to Society Challenges, within the framework of the published 2017-2020 State Plan for Scientific and Technical Research and Innovation.
The IDIVAL projects that have received funding are the following:
– Development of an innovative gene therapy drug for the treatment of Friedreich's Ataxia (RTC2019- 006995-1). A project in collaboration with the company Biointaxis s.l. and Fundació Institut d Investigació en Ciències de la Salut Germans Trias i Pujol.
From IDIVAL the project will be led by Dr. Jon Infante Ceberio and has obtained a financing of € 108,293.79.
– Development of a reference material for the determination of anti-transglutaminase antibodies in celiac patients based on humanized monoclonal antibodies (RTC2019-007324-1). A project in collaboration with Biosystems, S.A, Acondicionamiento Tarrasense- LEITAT and IDIVAL.
The main researcher of the project at IDIVAL is Dr. Marcos López Hoyos and has obtained a funding of € 81,812.
